AI Engines For more Details: Perplexity Kagi Labs You
Pain Relief: Benzocaine provides temporary relief from pain and discomfort associated with sore throat, mouth ulcers, teething pain, and minor skin irritations. It works by blocking nerve signals in the affected area, resulting in temporary numbness and pain relief.
Sore Throat: Benzocaine is often found in throat lozenges, sprays, and gargles designed to provide relief from sore throat pain. It numbs the throat tissues, reducing the sensation of pain and irritation, and may also help suppress coughing associated with sore throat.
Mouth Ulcers: Benzocaine-containing products such as gels and creams are used topically to numb the pain caused by mouth ulcers (canker sores) and other oral lesions. This can help alleviate discomfort and facilitate eating and drinking.
Teething Pain: Benzocaine is sometimes used in oral gels and solutions designed to relieve teething pain in infants and young children. It temporarily numbs the gums, providing relief from the discomfort associated with teething.
Minor Skin Irritations: Benzocaine-containing creams, ointments, and sprays can be applied topically to relieve pain and itching caused by minor skin irritations, insect bites, and sunburns.
Topical Anesthetic: Benzocaine is widely used as a topical anesthetic for various medical procedures, including minor surgical procedures, catheter insertion, and wound care. It helps reduce pain and discomfort during these procedures by numbing the skin or mucous membranes.
Hemorrhoids: Benzocaine-containing creams and ointments are sometimes used to relieve pain and discomfort associated with hemorrhoids (piles) and anal fissures. It temporarily numbs the affected area, reducing pain and itching.
Rank | Probiotic | Impact |
---|---|---|
species | Akkermansia muciniphila | Reduces |
species | Bifidobacterium adolescentis | Reduces |
species | Bifidobacterium longum | Reduces |
species | Escherichia coli | Reduces |
species | Lacticaseibacillus paracasei | Reduces |
subspecies | Bifidobacterium longum subsp. infantis | Reduces |
subspecies | Bifidobacterium longum subsp. longum | Reduces |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
---|---|---|---|
Abdominal Aortic Aneurysm | 0.4 | 0.4 | |
Acne | 0.5 | -0.5 | |
ADHD | 7.5 | 1 | 6.5 |
Age-Related Macular Degeneration and Glaucoma | 1 | 0.5 | 1 |
Allergic Rhinitis (Hay Fever) | 3 | 2.5 | 0.2 |
Allergies | 7.4 | 4.3 | 0.72 |
Allergy to milk products | 2.4 | 1.5 | 0.6 |
Alopecia (Hair Loss) | 2.5 | 2.5 | |
Alzheimer's disease | 6.1 | 9.7 | -0.59 |
Amyotrophic lateral sclerosis (ALS) Motor Neuron | 5.7 | 2.2 | 1.59 |
Ankylosing spondylitis | 6.4 | 3 | 1.13 |
Anorexia Nervosa | 0.5 | 3.5 | -6 |
Antiphospholipid syndrome (APS) | 3.4 | 0.4 | 7.5 |
Asthma | 2 | 2.2 | -0.1 |
Atherosclerosis | 2 | 3.4 | -0.7 |
Atrial fibrillation | 5.5 | 3.3 | 0.67 |
Autism | 16.1 | 15.1 | 0.07 |
Barrett esophagus cancer | 1 | 0.5 | 1 |
benign prostatic hyperplasia | 0.5 | 0.5 | |
Bipolar Disorder | 2.3 | 2.5 | -0.09 |
Brain Trauma | 1 | 1 | 0 |
Carcinoma | 5.8 | 4 | 0.45 |
Celiac Disease | 3.9 | 6.3 | -0.62 |
Cerebral Palsy | 2.4 | 2 | 0.2 |
Chronic Fatigue Syndrome | 9 | 10 | -0.11 |
Chronic Kidney Disease | 4 | 3 | 0.33 |
Chronic Lyme | 1 | -1 | |
Chronic Obstructive Pulmonary Disease (COPD) | 3.5 | 1.5 | 1.33 |
Chronic Urticaria (Hives) | 2.9 | 2.8 | 0.04 |
Coagulation / Micro clot triggering bacteria | 2.4 | 2 | 0.2 |
Colorectal Cancer | 7.8 | 1.5 | 4.2 |
Constipation | 2.5 | 1 | 1.5 |
Coronary artery disease | 2.5 | 1.5 | 0.67 |
COVID-19 | 18.7 | 22.7 | -0.21 |
Crohn's Disease | 13 | 9.4 | 0.38 |
cystic fibrosis | 1.4 | 1.5 | -0.07 |
deep vein thrombosis | 1.4 | 1.5 | -0.07 |
Depression | 16.3 | 13.7 | 0.19 |
Dermatomyositis | 0.5 | 0.5 | 0 |
Eczema | 2 | 3.5 | -0.75 |
Endometriosis | 4.9 | 2 | 1.45 |
Eosinophilic Esophagitis | 0.5 | 0.5 | 0 |
Epilepsy | 4.8 | 4.2 | 0.14 |
Fibromyalgia | 4.5 | 4.5 | 0 |
Functional constipation / chronic idiopathic constipation | 9.4 | 6.5 | 0.45 |
gallstone disease (gsd) | 3.5 | 1.5 | 1.33 |
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus | 3 | 1.5 | 1 |
Generalized anxiety disorder | 3.4 | 3 | 0.13 |
giant cell arteritis | 0.5 | -0.5 | |
Glioblastoma | 0.5 | -0.5 | |
Gout | 0.5 | -0.5 | |
Graves' disease | 2 | 2 | 0 |
Halitosis | 1.5 | 0.5 | 2 |
Hashimoto's thyroiditis | 3.9 | 1.4 | 1.79 |
Hidradenitis Suppurativa | 1.3 | 0.5 | 1.6 |
Histamine Issues,Mast Cell Issue, DAO Insufficiency | 5.4 | 1.5 | 2.6 |
hypercholesterolemia (High Cholesterol) | 1 | 0.8 | 0.25 |
hyperglycemia | 0.5 | 3.2 | -5.4 |
Hyperlipidemia (High Blood Fats) | 1.4 | 0.5 | 1.8 |
hypersomnia | 0.9 | -0.9 | |
hypertension (High Blood Pressure | 3.9 | 7.8 | -1 |
Hypothyroidism | 2 | -2 | |
Hypoxia | 1.4 | 1.4 | |
IgA nephropathy (IgAN) | 7 | -7 | |
Inflammatory Bowel Disease | 7.9 | 13.7 | -0.73 |
Insomnia | 1.5 | 1.5 | 0 |
Intelligence | 2 | 1 | 1 |
Intracranial aneurysms | 2 | 0.5 | 3 |
Irritable Bowel Syndrome | 7.2 | 6.8 | 0.06 |
Liver Cirrhosis | 7.7 | 5.3 | 0.45 |
Long COVID | 13.8 | 13.8 | 0 |
Low bone mineral density | 1.5 | -1.5 | |
Lung Cancer | 1.5 | 2.3 | -0.53 |
ME/CFS with IBS | 2 | 4 | -1 |
ME/CFS without IBS | 3.5 | 3.5 | 0 |
Menopause | 3 | 3 | |
Metabolic Syndrome | 13.1 | 13.9 | -0.06 |
Mood Disorders | 21 | 14.2 | 0.48 |
multiple chemical sensitivity [MCS] | 2.4 | 0.5 | 3.8 |
Multiple Sclerosis | 9.5 | 9 | 0.06 |
Multiple system atrophy (MSA) | 3.2 | 1.5 | 1.13 |
Neuropathy (all types) | 1.4 | 0.5 | 1.8 |
neuropsychiatric disorders (PANDAS, PANS) | 1.4 | 1.4 | |
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 4 | 8.3 | -1.08 |
NonCeliac Gluten Sensitivity | 0.5 | -0.5 | |
Obesity | 13.7 | 8.2 | 0.67 |
obsessive-compulsive disorder | 10.9 | 7.3 | 0.49 |
Osteoarthritis | 4 | 0.5 | 7 |
Osteoporosis | 3 | 1.8 | 0.67 |
pancreatic cancer | 1 | 1 | |
Parkinson's Disease | 5.5 | 6.9 | -0.25 |
Polycystic ovary syndrome | 4 | 3.4 | 0.18 |
Postural orthostatic tachycardia syndrome | 0.5 | 1 | -1 |
Premenstrual dysphoric disorder | 1.5 | 0.5 | 2 |
primary biliary cholangitis | 0.5 | 1.5 | -2 |
Psoriasis | 7.3 | 4.8 | 0.52 |
rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 11.2 | 6 | 0.87 |
Rosacea | 2 | 1 | 1 |
Schizophrenia | 11.2 | 3 | 2.73 |
scoliosis | 0.5 | 1.9 | -2.8 |
Sjögren syndrome | 5 | 5 | 0 |
Sleep Apnea | 2.5 | 2.5 | 0 |
Small Intestinal Bacterial Overgrowth (SIBO) | 1.9 | 1 | 0.9 |
Stress / posttraumatic stress disorder | 4.8 | 4.3 | 0.12 |
Systemic Lupus Erythematosus | 7.3 | 3 | 1.43 |
Tic Disorder | 2 | 2.5 | -0.25 |
Tourette syndrome | 0.4 | 0.5 | -0.25 |
Type 1 Diabetes | 6.3 | 4 | 0.57 |
Type 2 Diabetes | 13.6 | 12 | 0.13 |
Ulcerative colitis | 4.9 | 9.1 | -0.86 |
Unhealthy Ageing | 10.2 | 3.4 | 2 |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.